PT Tempo Scan Pacific Tbk (TSPC.JK)
IDR 2430.0
(-1.62%)
IDR 2430.0
(-1.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3250.09 Billion IDR | -13.98% |
| 2022 | 3778.21 Billion IDR | 36.45% |
| 2021 | 2769.02 Billion IDR | 1.53% |
| 2020 | 2727.42 Billion IDR | 5.64% |
| 2019 | 2581.73 Billion IDR | 5.93% |
| 2018 | 2437.12 Billion IDR | 3.58% |
| 2017 | 2352.89 Billion IDR | 20.63% |
| 2016 | 1950.53 Billion IDR | 0.15% |
| 2015 | 1947.58 Billion IDR | 33.36% |
| 2014 | 1460.39 Billion IDR | -5.48% |
| 2013 | 1545 Billion IDR | 20.72% |
| 2012 | 1279.82 Billion IDR | 6.26% |
| 2011 | 1204.43 Billion IDR | 27.47% |
| 2010 | 944.86 Billion IDR | 15.28% |
| 2009 | 819.64 Billion IDR | 24.96% |
| 2008 | 655.93 Billion IDR | 17.47% |
| 2007 | 558.36 Billion IDR | 24.83% |
| 2006 | 447.31 Billion IDR | -5.32% |
| 2005 | 472.47 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3415.2 Billion IDR | 5.08% |
| 2024 Q3 | 3223.4 Billion IDR | -6.8% |
| 2024 Q2 | 3458.62 Billion IDR | 1.27% |
| 2023 Q3 | 3242.02 Billion IDR | -9.47% |
| 2023 FY | 3250.09 Billion IDR | -13.98% |
| 2023 Q4 | 3250.09 Billion IDR | 0.25% |
| 2023 Q1 | 3404.83 Billion IDR | -9.88% |
| 2023 Q2 | 3581.03 Billion IDR | 5.17% |
| 2022 Q4 | 3778.21 Billion IDR | 10.25% |
| 2022 Q2 | 3590.81 Billion IDR | 11.31% |
| 2022 Q1 | 3226.09 Billion IDR | 16.51% |
| 2022 Q3 | 3427.04 Billion IDR | -4.56% |
| 2022 FY | 3778.21 Billion IDR | 36.45% |
| 2021 FY | 2769.02 Billion IDR | 1.53% |
| 2021 Q1 | 3027.02 Billion IDR | 10.98% |
| 2021 Q4 | 2769.02 Billion IDR | -5.3% |
| 2021 Q2 | 3063.2 Billion IDR | 1.2% |
| 2021 Q3 | 2923.88 Billion IDR | -4.55% |
| 2020 Q1 | 2780.8 Billion IDR | 7.71% |
| 2020 Q4 | 2727.42 Billion IDR | -2.81% |
| 2020 FY | 2727.42 Billion IDR | 5.64% |
| 2020 Q3 | 2806.4 Billion IDR | 0.17% |
| 2020 Q2 | 2801.67 Billion IDR | 0.75% |
| 2019 Q3 | 2287.5 Billion IDR | -7.04% |
| 2019 Q1 | 2445.92 Billion IDR | 0.36% |
| 2019 Q2 | 2460.72 Billion IDR | 0.61% |
| 2019 FY | 2581.73 Billion IDR | 5.93% |
| 2019 Q4 | 2581.73 Billion IDR | 12.86% |
| 2018 Q4 | 2437.12 Billion IDR | 6.11% |
| 2018 Q3 | 2296.82 Billion IDR | -9.29% |
| 2018 Q2 | 2532.01 Billion IDR | 13.54% |
| 2018 Q1 | 2229.98 Billion IDR | -5.22% |
| 2018 FY | 2437.12 Billion IDR | 3.58% |
| 2017 Q3 | 2176.22 Billion IDR | -15.02% |
| 2017 Q1 | 2178.84 Billion IDR | 11.7% |
| 2017 Q2 | 2560.9 Billion IDR | 17.54% |
| 2017 Q4 | 2352.89 Billion IDR | 8.12% |
| 2017 FY | 2352.89 Billion IDR | 20.63% |
| 2016 Q1 | 2027.38 Billion IDR | 4.1% |
| 2016 FY | 1950.53 Billion IDR | 0.15% |
| 2016 Q4 | 1950.53 Billion IDR | -1.15% |
| 2016 Q3 | 1973.23 Billion IDR | -11.74% |
| 2016 Q2 | 2235.81 Billion IDR | 10.28% |
| 2015 Q2 | 1922.07 Billion IDR | 25.91% |
| 2015 FY | 1947.58 Billion IDR | 33.36% |
| 2015 Q1 | 1526.51 Billion IDR | 4.53% |
| 2015 Q4 | 1947.58 Billion IDR | 22.18% |
| 2015 Q3 | 1594.01 Billion IDR | -17.07% |
| 2014 Q3 | 1328.4 Billion IDR | -21.49% |
| 2014 FY | 1460.39 Billion IDR | -5.48% |
| 2014 Q2 | 1692.06 Billion IDR | 27.93% |
| 2014 Q1 | 1322.62 Billion IDR | -14.39% |
| 2014 Q4 | 1460.39 Billion IDR | 9.94% |
| 2013 Q1 | 1311.72 Billion IDR | 2.49% |
| 2013 FY | 1545 Billion IDR | 20.72% |
| 2013 Q3 | 1389.59 Billion IDR | -12.4% |
| 2013 Q2 | 1586.37 Billion IDR | 20.94% |
| 2013 Q4 | 1545 Billion IDR | 11.18% |
| 2012 Q1 | 1172.36 Billion IDR | -2.66% |
| 2012 FY | 1279.82 Billion IDR | 6.26% |
| 2012 Q3 | 1248.59 Billion IDR | -19.98% |
| 2012 Q4 | 1279.82 Billion IDR | 2.5% |
| 2012 Q2 | 1560.43 Billion IDR | 33.1% |
| 2011 FY | 1204.43 Billion IDR | 27.47% |
| 2011 Q4 | 1204.43 Billion IDR | 0.0% |
| 2010 FY | 944.86 Billion IDR | 15.28% |
| 2009 FY | 819.64 Billion IDR | 24.96% |
| 2008 FY | 655.93 Billion IDR | 17.47% |
| 2007 FY | 558.36 Billion IDR | 24.83% |
| 2006 FY | 447.31 Billion IDR | -5.32% |
| 2005 FY | 472.47 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 639.05 Billion IDR | -408.58% |
| PT Merck Tbk | 161.93 Billion IDR | -1907.032% |
| PT Phapros, Tbk | 995.56 Billion IDR | -226.459% |
| PT Pyridam Farma Tbk | 1164.17 Billion IDR | -179.176% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 504.76 Billion IDR | -543.883% |